Emerging multidrug-resistant Candida auris: information on infection control practices
The following information was sent to PICNet's Community of Practice on July 14, 2016; you can also download the following information as a PDF. PICNet has also prepared a Q&A that you can view in our previous news post or as a PDF. Background The US Centers for Disease Control and Prevention and the Public Health Agency of Canada have recently raised an alert to an emerging multidrug-resistant (MDR) yeast, Candida auris (C....
Candida auris Q&A
PICNet has prepared the following Q&A to assist you with questions from staff or patients. You can also download this information as a PDF. View our subsequent news post for infection control and laboratory testing information. What is Candida auris? Is it a new type of infection? Candida auris is a type of Candida yeast. Candida yeasts normally live on the skin and mucous membranes but can cause yeast infections. C. auris was first identified in...
Emerging global HAI-AMR issue: Candida auris
PHAC communication PHAC has recently learned of a public health alert from US CDC in relation to the global emergence of invasive infections caused by the multidrug-resistant yeast organism, Candida auris. While C. auris is not common, it can cause invasive infections associated with high mortality and has also been known to cause outbreaks in healthcare facilities. Information available to date indicates that cases of C. auris have occurred in at least nine...